Chicago-based CRISPR technology company Syntax Bio says it has developed tech which automates the slow, manual process of ...
As someone who owns more than fifteen volumes from the MIT Press Essential Knowledge series, I approach each new release with both interest and caution: the series often delivers thoughtful, ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
You can prompt an AI model with a line of text, and it will generate most of the code needed to build an app, tool or website ...